Pharmaceuticals

Nephrology Drugs Market Expansion Outlook: $22.61 Billion by 2029 Forecast

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Nephrology Drugs Market From 2025 To 2034?

The nephrology drugs market size has exhibited consistent expansion over recent years. It is projected to expand from $16.88 billion in 2024 to $17.69 billion by 2025, recording a compound annual growth rate (CAGR) of 4.8%. The growth experienced in earlier periods is attributable to the increasing prevalence of chronic kidney diseases (CKD), developments in drug formulation, improved public awareness and diagnosis, governmental initiatives and healthcare policies, and a higher incidence of diabetes.

The nephrology drugs market size is set for robust expansion over the next few years, with projections indicating it will reach $22.61 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.3%. This anticipated growth during the forecast period is primarily driven by factors such as emerging therapies and drug innovations, the adoption of precision medicine and personalized treatment approaches, increasing healthcare expenditure, the rise of telehealth and remote patient monitoring, and various global health initiatives. Concurrently, major trends expected in this period encompass collaborations and partnerships, significant technological advancements in dialysis, improvements in treatment modalities, a growing emphasis on early diagnosis and intervention, and enhanced technological integration in nephrology management.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp

What Are The Drivers Pushing New Developments In The Nephrology Drugs Market?

The growing occurrence of chronic kidney disease is anticipated to boost the nephrology drugs market. Chronic kidney disease (CKD) refers to impaired kidneys that struggle to filter blood, gradually leading to a buildup of waste in the body. Nephrology drugs are primarily utilized in the management of CKD to improve kidney function and slow the disease’s progression, preventing further damage. For example, reports from the US-based Centers for Disease Control and Prevention (CDC) in July 2022 estimated that over 37 million people in the US had chronic kidney disease, being more common in those aged 65 years or older (38 percent). Furthermore, the Kidney Foundation of Canada, a Canadian non-profit, reports that 4 million Canadians are afflicted with kidney diseases, and 35 percent of diabetic patients are a leading cause of kidney failure. These numbers are expected to climb, thus driving the growth of the nephrology drug market due to the increasing prevalence of chronic kidney disease.

What Are The Major Segments Identified In The Nephrology Drugs Market?

The nephrology drugs market covered in this report is segmented –

1) By Drugs: Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Antihypertensive Agents: Calcium Channel Blockers, Beta-Blockers, Angiotensin II Receptor Blockers (ARBs)

2) By Erythropoiesis-Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa

3) By Diuretics: Loop Diuretics, Thiazide Diuretics, Potassium-Sparing Diuretics

4) By ACE Inhibitors: Lisinopril, Enalapril

5) By Antidiabetic Agents: Metformin, Insulin

6) By Other Drugs: Phosphate Binders, Vitamin D Analogues, Renin Inhibitors

How Are Emerging Market Trends Shaping The Nephrology Drugs Industry Landscape?

Product innovation represents a significant trend gaining momentum within the nephrology drug market. Major entities operating in the nephrology drug market are introducing new products and medications to secure their position in the sector. For instance, in March 2022, Zydus Lifesciences Limited, an Indian pharmaceutical company, unveiled Oxemia (desidustat) for chronic kidney disease (CKD). This medication functions as an oral, small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, presenting a practical therapeutic option for treating anemia. It received approval from the Drug Controller General of India. Clinical trials in Phase III revealed strong safety profiles, downregulation of hepcidin, enhanced iron mobilization, and a reduction in LDL-C among individuals with chronic kidney disease. Additionally, by offering treatment at a reasonable cost and improving patients’ quality of life, this development is expected to lessen the overall disease burden.

Which Global Market Leaders Are Shaping The Future Of The Nephrology Drugs Sector?

Major companies operating in the nephrology drugs market include AstraZeneca plc, AbbVie Inc., Akebia Therapeutics Inc., Amgen Inc., F. Hoffmann-La Roche AG, FibroGen Inc., Johnson And Johnson, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Boehringer Ingelheim International GmbH, Reata Pharmaceuticals Inc., Ardelyx Inc., Novo Nordisk A/S, Novartis AG, Baxter International Inc., Bristol Myers Squibb Company, Kissei Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals, OPKO Health Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Vifor Pharma Group, Bayer AG, Amicus Therapeutics, Chugai Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Mylan N.V., Endo Pharmaceuticals plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

Which Regional Markets Are Contributing Most To The Nephrology Drugs Industry Expansion?

North America was the largest region in the nephrology drug market in 2024.Europe will be the second-largest growing region in the nephrology drug market in 2024. The regions covered in the nephrology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Nephrology Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10076&type=smp

Browse Through More Reports Similar to the Global Nephrology Drugs Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795